SOX11 and breast cancer: Prognostic biomarker [28] for BC with elevated risk of distant metastases and poor outcome [135], therapeutic target [28]; ER negative DCIS SOX11+ tumor cells metastasize to brain and bone at greater frequency than in lungs [135]